CNS II- Neurodegenerative Disorders/ Parkinson's Disease Flashcards
What is neurodegeneration?
Progressive loss of neuronal function, typified by neuronal cell death (apoptosis or necrosis) and protein aggregates (inclusion bodies)
What are the 4 main neurodegenerative disorders to know?
- Alzheimer’s (most common)
- Parkinson’s
- Huntington’s
- Amyotrophic Lateral Sclerosis (ALS)
What kind of inclusion bodies are associated with Parkinson’s disease?
Lewy bodies
What are the major symptoms of Parkinson’s disease?
Major Symptoms of Parkinson’s disease:
- Resting tremor (abates during voluntary movement)
- Bradykinesia, akinesia (slowness, lack of movement)
- Muscular rigidity
- Postural instability (disturbances of gait, falling {PD+})
- Dementia
“TRAP”–> tremor, rigidity, akinesia, postural
Which neurons are destroyed in Parkison’s disease?
The dopaminergic neurons that project to the neostriatum from the substantia nigra pars compacta are selectively and progressively destroyed.
What forms the extrapyramidal motor system (EPS)?
The neostriatum (basal ganglia)
What happens when the EPS is damaged?
- Depression in the ability to initiate voluntary movements
- Causes involuntary movements (ie/ resting tremor, huntington’s)
What are the risk factors for developing Parkinson’s?
- Genetic (10-15% familial)
- Age
- illness (CNS infection, perhaps viral) - Environment toxins (herbicides, rotenone, MPTP)
- Oxidative stress
- mitochondrial dysfunction
- nitric oxide production
- loss of reduced glutathione - Glutamate excitotoxicity
- Protein misfolding and impaired degradation
- Mutations, e.g. Parkin, polygenetic origins
What is the net result of the direct DA pathway?
Produces excitatory input to the motor cortex
What is the net result of the indirect DA pathway?
Produces inhibitory input to the motor cortex. HOWEVER–> D2 inhibits the indirect pathway, which ultimately produces excitatory input to motor cortex
What is the major goal of pharmacological treatment in PD?
Major goal of pharmacological treatment of PD is to improve DA neurotransmission from the SNpc to the neostriatum.
This is accomplished by attempting to elevate DA levels in the SNpc
Why don’t we use dopamine to treat PD?
Because it does not cross the BBB
What are the dopamine precursors?
Levodopa
Carbidopa- inhibits peripheral conversion of L-DOPA to dopamine (inhibits AAD)
Levodopa/Carbidopa (#1 initial therapy for PD)
What are the dopamine receptor agonists?
Pergolide (PERMAX) (taken off the market--> side effect of cardiac valve regurgitation) Bromocriptine (PARLODEL) Ropinirole (REQUIP) Pramipexole (MIRAPEX) Rotigotine (NEUPRO) (recalled in 2008) Apomorphine (APOKYN)
What are the COMT inhibitors?
Entacapone (COMTAN)
Tolcapone (TASMAR)
Levodopa\carbidopa\entacapone (STALEVO)